ENZB — Enzo Biochem Cashflow Statement
0.000.00%
Last trade - 00:00- $25.67m
- -$14.41m
- $31.91m
- 55
- 62
- 28
- 46
Annual cashflow statement for Enzo Biochem, fiscal year end - July 31st, USD millions except per share, conversion factor applied.
2020 July 31st | 2021 July 31st | 2022 July 31st | 2023 July 31st | 2024 July 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -28.5 | 7.88 | -18.3 | 20.3 | -26.1 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.604 | -5.37 | 5.68 | -78.5 | 6.8 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 7.96 | -4.77 | -6.83 | 18.6 | -8.25 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -17.2 | 0.387 | -16.6 | -37 | -26.3 |
| Capital Expenditures | -2.17 | -4.44 | -3.47 | -2.76 | -0.545 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | -30.1 | 28.7 | 102 | 0 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.17 | -34.5 | 25.2 | 99 | -0.545 |
| Financing Cash Flow Items | 0 | 0 | — | -0.389 | -0.474 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7 | -0.242 | -0.241 | -1.13 | -4.19 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -12.3 | -34.3 | 8.33 | 60.8 | -31 |